Experimental prescription, rising resistance: the alarming misuse of ceftazidime-avibactam in healthcare systems.
Mojtaba Akbari, Christian G Giske, Hamid Solgi
Author Information
- Mojtaba Akbari: Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- Christian G Giske: Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
- Hamid Solgi: Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
No abstract text available.
- Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):2023-2027
[PMID: 39073671]
- Antibiotics (Basel). 2024 Mar 15;13(3):
[PMID: 38534695]
- Lancet Reg Health Southeast Asia. 2023 May 27;15:100225
[PMID: 37614349]
- Clin Infect Dis. 2019 Nov 13;69(Suppl 7):S565-S575
[PMID: 31724043]
- Iran J Microbiol. 2023 Oct;15(5):609-615
[PMID: 37941881]
